The information contained on this web page is only a summary of information presented in more detail in the Notice of Pendency of Class Action, Proposed Settlement, and Motion for Attorneys’ Fees and Expenses (the “Notice” ), which you can access by clicking here . Since this website is just a summary, you should review the Notice for additional information.

If you are a Class Member, your legal rights will be affected by this Settlement whether you act or do not act.

If you purchased or otherwise acquired LifeStance Health Group, Inc. (“LifeStance” or the “Company”) common stock pursuant and/or traceable to LifeStance’s June 10, 2021 initial public offering (“IPO”) and no later than November 8, 2021, you may be entitled to a payment from a class action settlement.

The Court has directed that everyone who fits the following description is a member of the Class and subject to the Settlement unless they are an excluded person (see Question 3 of the Notice for details) or take steps to exclude themselves from the Class (see Question 10 of the Notice for details):

On January 24, 2024 the Court held a Settlement Hearing to determine whether: (i) the Settlement is fair, reasonable, adequate, and should be approved; (ii) the Plan of Allocation is fair and reasonable and should be approved; and (iii) the application of Lead Counsel for an award of attorneys’ fees and payment of Litigation Expenses is reasonable and should be approved. The Court has since granted Plaintiff’s Motion for Final Approval of the Settlement, Lead Counsel’s Motion for an Award of Attorneys’ Fees and Expenses and an Award to Lead Plaintiff, and approved the Plan of Allocation. The relevant orders can be found in the Court Documents page of this website.

For more details regarding this case, please reference the documents filed in the case under the “Court Documents” section at the top of this website. You may also contact the Claims Administrator for further information regarding this case.